Omalizumab treatment downregulates dendritic cell FcεRI expressionCalman Prussin, Thomas B. Casale, D.T. Griffith et al.|Journal of Allergy and Clinical Immunology|2003Cited by 346
Omalizumab rapidly decreases nasal allergic response and FcεRI on basophilsHenry C. Lin, Thomas B. Casale, K.M. Boesel et al.|Journal of Allergy and Clinical Immunology|2004Cited by 267
Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary AtresiaBenjamin L. Shneider, Emily Elgert, John C. Magee et al.|The Journal of Pediatrics|2015Cited by 146
Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALABettina E. Hansen, Piotr Czubkowski, Dorota Gliwicz‐Miedzińska et al.|Hepatology|2023Cited by 33
Serum bile acids are associated with native liver survival in patients with Alagille syndrome: results from the GALA study groupCarla Fiorella Murillo Perez, Rima Fawaz, Shannon M. Vandriel et al.|Journal of Hepatology|2023Cited by 0